The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • Gene obtained from curated document aligns with the Allele Registry but not with ClinVar data
  • cspec.ruleSetIri property did not resolve into a valid CSPEC request: https://cspec.genome.network/cspec-priv/RuleSet/id/1530970184!
  • cspecId property did not resolve into a valid CSPEC request: https://cspec.genome.network/cspec-priv/SequenceVariantInterpretation/id/1530970171!
  • No CSPEC computed assertion could be determined for this classification!

  • No Criteria Specification was provided in the publication event for the variant classifaction.
  • The Criteria Specification shown below is a best-estimate based on the VCEP, gene, disease, and publication date.

Variant: NM_007294.4(BRCA1):c.4211T>G (p.Leu1404Arg)

CA059655

491071 (ClinVar)

Gene: BRCA1 (HGNC:672)
Condition: BRCA1-related cancer predisposition (MONDO:0700268)
Inheritance Mode: Autosomal dominant inheritance
UUID: d18a7e33-2187-4ff7-a147-eadb7ab11b60
Approved on: 2025-12-03
Published on: 2025-12-02

HGVS expressions

NM_007294.4(BRCA1):c.4211T>G (p.Leu1404Arg)
NM_007294.4:c.4211T>G
NC_000017.11:g.43082550A>C
CM000679.2:g.43082550A>C
NC_000017.10:g.41234567A>C
CM000679.1:g.41234567A>C
NC_000017.9:g.38488093A>C
NG_005905.2:g.135434T>G
ENST00000461574.2:c.4211T>G
ENST00000470026.6:c.4211T>G
ENST00000473961.6:c.4085T>G
ENST00000476777.6:c.4205T>G
ENST00000477152.6:c.4133T>G
ENST00000478531.6:c.899T>G
ENST00000489037.2:c.4133T>G
ENST00000493919.6:c.761T>G
ENST00000494123.6:c.4211T>G
ENST00000497488.2:c.3323T>G
ENST00000618469.2:c.4211T>G
ENST00000634433.2:c.4088T>G
ENST00000644379.2:c.4211T>G
ENST00000644555.2:c.761T>G
ENST00000652672.2:c.4070T>G
ENST00000484087.6:c.776T>G
ENST00000700182.1:c.821T>G
ENST00000357654.9:c.4211T>G
ENST00000471181.7:c.4211T>G
ENST00000644379.1:c.532T>G
ENST00000352993.7:c.785T>G
ENST00000357654.7:c.4211T>G
ENST00000461221.5:c.*3994T>G
ENST00000461574.1:c.505T>G
ENST00000468300.5:c.902T>G
ENST00000471181.6:c.4211T>G
ENST00000478531.5:c.899T>G
ENST00000484087.5:c.524T>G
ENST00000487825.5:c.527T>G
ENST00000491747.6:c.902T>G
ENST00000493795.5:c.4070T>G
ENST00000493919.5:c.761T>G
ENST00000586385.5:c.5-18599T>G
ENST00000591534.5:c.-43-8029T>G
ENST00000591849.5:c.-98-32360T>G
ENST00000621897.1:n.105T>G
NM_007294.3:c.4211T>G
NM_007297.3:c.4070T>G
NM_007298.3:c.902T>G
NM_007299.3:c.902T>G
NM_007300.3:c.4211T>G
NR_027676.1:n.4347T>G
NM_007297.4:c.4070T>G
NM_007299.4:c.902T>G
NM_007300.4:c.4211T>G
NR_027676.2:n.4388T>G
More

Uncertain Significance

Met criteria codes 3
BP4 PM2_Supporting PP1
Not Met criteria codes 1
PP3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
ENIGMA BRCA1 and BRCA2 VCEP
The c.4211T>G variant in BRCA1 is a missense variant predicted to cause substitution of Leucine by Arginine at amino acid 1404 (p.(Leu1404Arg)). This variant is absent from gnomAD v4.1 (read depth ≥25) (PM2_Supporting met). This BRCA1 missense variant is within a key functional domain and the computational predictor BayesDel (noAF) gives a score of 0.09, which is below the recommended threshold of 0.15 for predicting no impact on BRCA1 via protein change. A SpliceAI score of 0.02 predicts no impact on splicing (score threshold ≤0.1) (BP4 met). Cosegregation analysis of one family carrying this variant provided evidence towards pathogenicity, and has a Bayes Score of 3.9 (applied as LR), within the thresholds for supporting pathogenic evidence (LR ≥2.08 & <4.3) (PP1 met; Internal lab contributor). In summary, this variant meets the criteria to be classified as a Variant of uncertain significance for BRCA1-related cancer predisposition based on the ACMG/AMP criteria applied as specified by the ENIGMA BRCA1/2 VCEP (BP4, PM2_Supporting, PP1).
Met criteria codes
BP4
This BRCA1 missense variant is within a key functional domain and the computational predictor BayesDel (noAF) gives a score of 0.09, which is below the recommended threshold of 0.15 for predicting no impact on BRCA1 via protein change. A SpliceAI score of 0.02 predicts no impact on splicing (score threshold ≤0.1) (BP4 met).
PM2_Supporting
This variant is absent from gnomAD v4.1 (read depth ≥25) (PM2_Supporting met).
PP1
Cosegregation analysis of one family carrying this variant provided evidence towards pathogenicity, and has a Bayes Score of 3.9 (applied as LR), within the thresholds for supporting pathogenic evidence (LR ≥2.08 & <4.3) (PP1 met; Internal lab contributor).
Not Met criteria codes
PP3
No code specific comments provided, please refer to the summary above or general recommendations provided in the guideline
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.